Onchilles Pharma Raises $7 Million Series A To Advance Drug Candidates To Activate Newly Discovered Broad-Acting Anticancer Pathway
Round Type
Series A
San DiegoBiotechnologyDescription
Onchilles Pharma announced today a $7 Million Series A financing from LYZZ Capital and includes a $500,000 investment from the University of Chicago’s Startup Investment Fund. The proceeds of the financing will be used to develop first-in-class therapeutics to activate a novel pathway of the innate immune system with potential for universal anti-cancer activity, independent of genetic mutation. Research published in today’s issue of Cell is the first to describe this pathway where human neutrophils release catalytically active neutrophil elastase, called ELANE, to selectively kill many cancer cell types while sparing non-cancer cells.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Onchilles Pharma that raised within 45 days of this round, from Fundz verified event records.
- Transcera Inc. raised $1M (Seed) on July 23, 2021.
- Wugen raised $99M on July 23, 2021.
- Wugen raised $37M on July 23, 2021.
- Arzeda raised $26M on July 22, 2021.
- Kandu Health™ raised $260M on July 22, 2021.
- Phytoform raised $5.5M on July 22, 2021.
Who to call at Onchilles Pharma, and when
A new round usually means Onchilles Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Onchilles Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Onchilles Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Onchilles Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Onchilles Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOnchilles Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.